Carcinogenesis, Teratogenesis & Mutagenesis

Previous Articles     Next Articles

Effects of Fas in combined treatment of TRAIL and arsenic trioxide- induced apoptosis in human gastric cancer cells

DUAN Xiao-qiu,WANG Jing,SHEN Wei-xi,YANG Yu*   

  1. Department of Medical Oncology, the Second Affiliated of Harbin Medical University 150081, Heilongjiang, China
  • Received:2012-04-16 Revised:2012-09-02 Online:2011-11-30 Published:2011-11-30
  • Contact: YANG Yu,E-mail:yangy@medmail.com.cn
  • About author:段晓秋(1983- ),女,山东省临沂市人,硕士研究生,研究方向:肿瘤的化学预防。
  • Supported by:

    黑龙江省自然科学基金资助项目(D200862)

Abstract:

OBJECTIVE: To study the effects of Fas in combined treatment of TRAIL(tumor necrosis factor-related apoptosis-inducing ligand) and arsenic trioxide(As2O3)-induced apoptosis in human gastric cancer SGC-7901 cells. METHODS: SGC-7901 cells were cultured in vitro, Sense and Antisense SGC-7901 cells were obtained from transfection of sense and antisense oligo nucleic acid, respectively. Untransfected, Sense and Antisense cells were treated with 0.5 μg/ml As2O3+0.2 μg/ml TRAIL, respectively. Cell proliferation was evaluated by MTT assay after 24, 48 and 72 h; cell colony morphologies were examined under inverted microscope after 48 h; apoptosis rate measured by DAPI staining and flow cytometer; and Fas, FADD and Parp expression determined by Western blot. RESULTS: Treatment by Fas antisense oligo nucleic acid transfection decreased the number of dead cells as detected by microscopy, exerted cell growth inhibition and As2O3+TRAIL-induced apoptosis effects. The expressions of Fas,FADD and activated Parp were all down-regulated (P<0.05). CONCLUSION: Fas signaling pathway may be important in the process of SGC-7901 apoptosis induced by combined treatment of As2O3 and TRAIL.

Key words: tumor necrosis factor-related apoptosis-inducing ligand;arsenic trioxide, apoptosis, gastric cancer cells SGC-7901, Fas